API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved

Contact Us

Web Copyright: Shijiazhuang No.4 Pharmaceutical Co., Ltd. Powered by www.300.cn 冀ICP备05007979号-1

Add: No. 288,Zhujiang Road, High-tech Industrial

Development,Shijiazhuang, Hebei, China
Web: www.sjzsiyao.com
Tel: 86 311 67167137 / 67167144
E-mail: trade@sjzsiyao.com / chinainfusion@163.com
Skype: xlmamary

About Us

Online Message

API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved

[Abstract]:

API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved Recently API Dexmedetomidine Hydrochloride developed and applied by Hebei Guolong Pharmaceutical Co., Ltd., SSY Group was approved by NMPA to be used for the FPF. FPF Dexmedetomidine Hydrochloride Injection (2ml:0.2mg) applied by SSY Group also got the MA from NMPA and treated as consistency evaluation completion. Dexmedetomidine is a α2 adrenergic receptor agonists, it is maily used for sedation during tracheal intubation and mechanical ventilation in patients undergoing surgery under general anesthesia.

API Dexmedetomidine Hydrochloride Manufactured by SSY Group was Approved

Recently API Dexmedetomidine Hydrochloride developed and applied by Hebei Guolong Pharmaceutical Co., Ltd., SSY Group was approved by NMPA to be used for the FPF.

FPF Dexmedetomidine Hydrochloride Injection (2ml:0.2mg) applied by SSY Group also got the MA from NMPA and treated as consistency evaluation completion.

Dexmedetomidine is a α2 adrenergic receptor agonists, it is maily used for sedation during tracheal intubation and mechanical ventilation in patients undergoing surgery under general anesthesia.

Shijiazhuang No. 4 Pharmaceutical Co., Ltd. is again ranking top 50 in China Chemical Drug R&D Strength

Vice Governor Ge Haijiao visited Shijiazhuang No.4 Pharmaceutical to check the supply and security of anti-epidemic materials